Valeant Pharmaceuticals (VRX) was trading at a forward EV-to-EBITDA (enterprise value to earnings before taxes, depreciation, and amortization) multiple of 5.64x on March 16, 2016. This looks to be a ...
Investors are typically fixated on the price-to-earnings (P/E) strategy while seeking stocks trading at attractive prices. This straightforward, easy-to-calculate ratio is the most preferred among all ...
Investors are typically fixated on the price-to-earnings (P/E) strategy while seeking stocks trading at attractive prices. This straightforward, easy-to-calculate ratio is the most preferred among all ...
We've identified the following companies as similar to null because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list ...
Chart Industries (NYSE:GTLS) and Flowserve (NYSE:FLS) announced Tuesday that they will merge in an all-stock transaction, creating a industrial-process technology giant valued at approximately $19 ...
We've identified the following companies as similar to null because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list ...